Moat Ross sold KNSA
April 1, 2026 · Form 4 insider transaction
Moat Ross sold 1,611 shares of Kiniksa Pharmaceuticals International, plc at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,611
Price
$0.00
Total value
N/A
InsiderMoat Ross
RoleOfficer
SecurityRestricted Share Unit
Transaction codeM: Option exercise
Transaction dateApril 1, 2026
Filing dateApril 3, 2026
Shares owned after1,161
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.; The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2023.